financetom
Business
financetom
/
Business
/
What's Going On With Alibaba Shares Today?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
What's Going On With Alibaba Shares Today?
May 30, 2025 12:56 PM

Alibaba Group Holding Ltd. ( BABA ) shares are trading lower Friday after a combination of political and legal developments reignited concerns over U.S.-China trade relations.

What To Know: On Thursday, President Donald Trump stated that China had violated its trade agreements with the United States. While he did not specify which terms were broken, his comments come as he continues to push for stricter trade enforcement. Shortly after his remarks, a U.S. federal appeals court temporarily reinstated most of the tariffs Trump had previously enacted using the International Emergency Economic Powers Act.

These tariffs had been struck down just a day earlier by a three-judge panel, which ruled that the International Emergency Economic Powers Act did not grant the president unlimited authority to impose tariffs. However, the Trump administration filed an appeal and the appellate court responded by putting the lower court's decision on hold, pending further review.

For Alibaba ( BABA ) and other U.S.-listed Chinese companies, this legal uncertainty adds pressure. The stock had previously seen upward movement when the court initially blocked the tariffs, but that optimism quickly reversed. Investors are now reassessing risk, especially as Alibaba ( BABA ) and peers like PDD Holdings and Baidu operate in a geopolitical environment prone to sudden shifts.

Earlier in May, China and the U.S. agreed to temporarily lower mutual tariffs for 90 days, with U.S. duties dropping from 145% to 30% and Chinese duties on American goods falling from 125% to 10%. That agreement provided short-term relief, but the recent court ruling and Trump's rhetoric suggest those reductions may be at risk if political dynamics change, especially with the upcoming election cycle.

BABA Price Action: Alibaba ( BABA ) shares were down 2.78% at $113.92 at the time of writing, according to Benzinga Pro.

Read Next:

Wall Street Slumps As Trump Reignites China Trade Tensions, Nvidia Wipes Out Earnings Rally: What’s Driving Markets Friday?

Image Via Shutterstock.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Interpace Biosciences Q3 revenue down 
Interpace Biosciences Q3 revenue down 
Nov 12, 2025
Overview * Interpace Q3 revenue falls 29% yr/yr, but rises 22% from pro forma results * Company reports record thyroid test volumes and cash collections in Q3 * Interpace focuses on lab efficiency and AI, supporting strategic investments Outlook * Company did not provide specific future guidance in press release Result Drivers * RECORD THYROID TEST VOLUME - Co achieved...
Merck & Co. Insider Sold Shares Worth $616,395, According to a Recent SEC Filing
Merck & Co. Insider Sold Shares Worth $616,395, According to a Recent SEC Filing
Nov 12, 2025
04:12 PM EST, 11/12/2025 (MT Newswires) -- Cristal N Downing, Chief Communications & Public Affairs Officer, on November 10, 2025, sold 7,085 shares in Merck & Co. ( MRK ) for $616,395. SEC Filing: https://www.sec.gov/Archives/edgar/data/310158/000031015825000061/xslF345X05/form4.xml ...
Natural gas producer Birchcliff's Q3 net loss widens
Natural gas producer Birchcliff's Q3 net loss widens
Nov 12, 2025
Overview * Birchcliff Q3 2025 production rose 7% yr/yr, driven by strong base and new well performance * Adjusted funds flow in Q3 2025 increased 93% yr/yr, driven by higher natural gas revenue * Birchcliff reported a net loss of C$14.1 mln in Q3 2025, due to unrealized losses on contracts Outlook * Birchcliff raises 2025 production guidance to 79,000-80,000...
Cancer diagnostics firm Celcuity posts smaller-than-expected Q3 adjusted loss per share 
Cancer diagnostics firm Celcuity posts smaller-than-expected Q3 adjusted loss per share 
Nov 12, 2025
Overview * Celcuity ( CELC ) Q3 adjusted loss per share and adjusted net loss beat analyst expectations * Company's operating expenses increased to $42.8 mln in Q3 2025 * Celcuity on track to submit NDA for gedatolisib in Q4 2025 Outlook * Celcuity expects topline data from PIK3CA mutant cohort in late Q1 2026 or Q2 2026 * Celcuity...
Copyright 2023-2026 - www.financetom.com All Rights Reserved